DECOY THERAPEUTICS INC.

Suspension of trading

Transcripts Decoy Therapeutics Inc. Börse Stuttgart

Stocks

FP11

US79400X6022

Biotechnology & Medical Research

Market Closed - Börse Stuttgart 11:48:59 2024-06-14 EDT			5-day change	1st Jan Change
3.104 ^EUR	-3.96%		+704.15%	+435.17%

08-12	Decoy Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-27	Decoy Therapeutics Demonstrates In Vitro Activity Of D-MAV Candidate Against Wild-Type Ebola Zaire Virus And Opens Exploratory Program To Design D-MAVs Against Filoviruses Including Ebola And Marburg	CI

Transcripts

04-09	Decoy Therapeutics Inc. - Special Call
22-12-14	Salarius Pharmaceuticals, Inc. - Special Call
22-08-08	Salarius Pharmaceuticals, Inc., Q2 2022 Earnings Call, Aug 08, 2022
22-05-12	Salarius Pharmaceuticals, Inc., Q1 2022 Earnings Call, May 12, 2022
22-03-10	Salarius Pharmaceuticals, Inc., Q4 2021 Earnings Call, Mar 10, 2022
22-01-13	Salarius Pharmaceuticals, Inc. - Special Call
21-11-04	Salarius Pharmaceuticals, Inc., Q3 2021 Earnings Call, Nov 04, 2021
21-08-05	Salarius Pharmaceuticals, Inc., Q2 2021 Earnings Call, Aug 05, 2021
21-06-21	Salarius Pharmaceuticals, Inc. - Special Call
21-03-18	Salarius Pharmaceuticals, Inc., Q4 2020 Earnings Call, Mar 18, 2021
20-09-01	Salarius Pharmaceuticals, Inc. Presents at LD Micro 500 Virtual Investor Conference, Sep-01-2020 03:20 PM
20-08-12	Salarius Pharmaceuticals, Inc., Q2 2020 Earnings Call, Aug 12, 2020
20-02-17	Salarius Pharmaceuticals, Inc. Presents at 16th Annual Noble Conference Emerging Growth Investor Conference, Feb-17-2020 05:00 PM

No results match your criteria

All News Broker Recommendations Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies

Filters

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

Unlock them now!